Groundbreaking Science And Medicine Intersect In Boston At The Powering Precision Health Summit
By Kevin Hrusovsky, Executive Chairman And CEO, Quanterix
As the National Institutes of Health continues to push its “All of Us” Research Program forward – an ambitious effort to gather data for over a million people living in the U.S to accelerate precision medicine research – medical professionals are also banding together to advance the science of precision health at the Powering Precision Health Summit (PPHS). After launching the conference last year, we are expecting that PPHS 2017 will be even bigger and more impactful, with over 500 attendees from around the world. We are thrilled to announce our speaker list that includes some of the brightest minds and industry thought leaders, spanning the gamut from leading researchers and academics to patients and scientific engineers – all who are working tirelessly to transform precision health.
Don’t just take my word for it though. Hear from our impressive roster of speakers from last year, many of whom are returning to the stage once again, about why the time is now for a precision medicine movement and the importance of this event in accelerating it.
“This is an extraordinary group of people to bring together to have a discussion at a particularly exciting time in precision medicine. I’m really excited about some of the connections we made today. I think the organizing committee brought together a very eclectic group, a very diverse group across disease areas, and across academia and industry. And a lot of the ideas that came out of today had very clear follow-on discussions that can happen and new collaborations that can be formed. So I think it created an impetus to continue the discussion, and I’m looking forward to seeing what the group can do next.” – Grace Colon, InCarda Therapeutics and ProterixBio
“I think there is a tremendous amount of optimism about the new technologies that are being brought to bear, both from the genetics field but also from the protein diagnostics arena, which is what this meeting is all about, that we think will have a dramatic effect on health care. It’s the early days; it’s possible that some of the things that we are discovering are going to be incredibly important, and are going to really change the way people are diagnosed in a wide variety of diseases. But as I said, it’s early days, so a lot of research and a lot of work remains to be done to get to a place where they’re going to make a difference and change the course of these dreadful diseases.” – Dr. David Walt, Harvard University
“We are the only profession in the world that doesn’t know its gold standard. We can diagnose disease reasonably well and its progression to death, but we can’t diagnose wellness and its progression to disease. And it’s in that regard that the assessment tools that are being discussed in pre-symptomatic disease management, will become essential for us to define the pattern of wellness, ultimately to slow or prevent its progression to disease.” – Dennis Ausiello, Massachusetts General Hospital
“I think it’s a great idea to get people together and discuss how new biomarkers increase the sensitivity of cardiac and cancer assays, and how all the biomarkers can drive precision medicine, how they can contribute to choosing the right diagnostic tools and right therapy for the patients.” – Petr Jarolim, Brigham and Women’s Hospital and Dana Farber Cancer Institute
“We’re at a time now where we must develop ways of detecting meaningful changes to the brain after getting hit. We can’t rely on people reporting symptoms. We can’t rely on coaches saying oh, that kid just had a big hit. And we can’t rely on just focusing on the concussions. We need great sensitive measures, using wonderful new digital technology, to detect what is going on in the brain when people get hit. That’s the starting point, so we could hopefully remove those people from the game, hopefully know when they should go back, when they are recovered. Perhaps know when people have had enough and they need to retire from the sport. We are at a time now where we need to use new technology, new digital biomarkers, to be able to detect brain injuries, these mild things, so we can, first of all, keep our kids healthy and safe, but then perhaps prevent them from going on to develop a brain disease later in life.” – Dr. Robert Stern, Boston University School of Medicine.
“Apart from the fact that it’s a great array of scientists presenting, I’m excited to hear about the advances in biomarker development and the technologies applied to that biomarker development. Highly sensitive detection systems, being able to look at proteins now and detect proteins at levels that weren’t seen before, and really allowing us the potential to diagnose disease much earlier. And if you can diagnose disease much earlier, we’ve got a better chance of helping the overall course of the disease for the patients. So, it’s a very exciting day!” – John Houston, PhD. Avinas LLC
Precision health means something different to every individual. For some, it’s a personal connection that they have to the term because of a loved one they lost that could have benefited from personalized treatment. For others, it’s a promising technique fueling their research and propelling medical advancement around the world. Whatever the case may be, we hope that you’ll join us on October 24 – 25 in Cambridge, MA. to learn about the latest research, technological advancements, as well as personal struggles and triumphs to turn today’s sick care into true, preventative healthcare.
Share this page